Compare the efficacy of rosuvastatin to atorvastatin in high risk patients with hypercholesterolemia

Study identifier:D356FC00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomised, double-blind trial to compare the efficacy of rosuvastatin 5 and 10 mg to atorvastatin 10 mg in the treatment of high risk patients with hypercholesterolemia followed by an open label treatment period with rosuvastatin up-titrated to the maximum dose of 20 mg for those patients who do not achieve goal

Medical condition

Hypercholesterolemia

Phase

Phase 3

Healthy volunteers

No

Study drug

Rosuvastatin, Atorvastatin

Sex

All

Actual Enrollment

934

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 May 2008
Primary Completion Date: 01 Jul 2009
Study Completion Date: 01 Jul 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Mar 2012 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria